Venture Capital

The popular brunch chain is betting on a digital marketing guru to transform its customer experience and accelerate growth in a tech-driven market.

WISeKey's satellite arm, WISeSat, is merging with a SPAC to build a quantum-resilient IoT network, a key step in securing future global communications.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

New York's Peripherii launches Priamble™, audio earrings blending luxury jewelry with open-ear tech. Is this the future of wearable sound for women?

A new deal links Mexico’s largest scouting academy with Spain's Cádiz CF, promising a direct route to European football for young talent.

With a novel therapy from newborn heart cells, Secretome Therapeutics heads to J.P. Morgan to showcase its progress against intractable heart failure.

HEYTEA's first global launch with POP MART's Twinkle Twinkle reveals a sophisticated strategy for world domination, one cup of new-style tea at a time.

The premier investor summit returns with a global tour, new sessions on real estate, and a renewed focus on funding critical pediatric cancer research.

The Department of War is funding a Montana firm to secure the U.S. supply chain for critical materials used in advanced thermal imaging and missile guidance.

Tired of ads and algorithms? Gistvox has launched an audio-only app with a radical idea: intentional listening. But can its unique business model survive?

A CETY affiliate moves its 2.2 MW Vermont plant through regulatory hurdles, but past setbacks, new technology, and financial questions loom large.

With a new HQ and $2M in contracts, Taoping is leveraging AI and government policy to modernize China's aging elevators, but faces investor scrutiny.

Ultragenyx's stock plummets after its Osteogenesis Imperfecta drug fails to reduce fractures, a major blow for patients and a test of the firm's pipeline.

A new VR experience from Braindance uses a radical rendering method to make virtual worlds feel less like a game and more like a place you can truly occupy.

As its cash runway shortens, Longeveron's novel stem cell therapy gets a major boost with selection for a prestigious Alzheimer's health moonshot.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

A Korean pet food brand's surprise win over tech giants at a top pitch event signals a major shift in what venture capitalists value. Here's why.

The investment firm sheds its medical focus, adopting a new name and a broader mandate to chase cross-sector opportunities in the booming AI market.